Health Bulletin 24/ December/ 2022 Roshni Dhar24 Dec 2022 4:32 PM ISTHere are the top health stories for the day:Fully prepared to deal with any eventuality, say Delhi hospitals amid coronavirus scareAmid concerns over...
Centre nod to Bharat Biotech nasal COVID vaccine iNCOVACC, to be availabile in private hospitals Ruchika Sharma23 Dec 2022 3:31 PM ISTiNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized SARS-CoV-2 spike protein.
Include intranasal COVID vaccine iNCOVACC in CoWIN portal: Bharat Biotech urges Centre Ruchika Sharma12 Dec 2022 12:30 PM ISTCurrently, Bharat Biotech's Covaxin, Serum Institute's Covishield and Covovax, Russian Sputink V, and Biological E Ltd's Corbevax are listed in the...
CDSCO nod to World's first intra-nasal COVID vaccine for restricted use Ruchika Sharma2 Dec 2022 12:00 PM ISTVaccine is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilized spike protein.
DCGI gives nod to Bharat Biotech Intranasal 'Five Arms' COVID booster dose for restricted use Ruchika Sharma26 Nov 2022 11:30 AM ISTThe nasal vaccine can be taken after six months of the second dose. As this is non-invasive and needle-free, it becomes easy to administer.
Scientific approach followed in Covaxin approval: Govt rebuts all allegations on Bharat Biotech Covaxin hurried approval Ruchika Sharma17 Nov 2022 3:30 PM ISTNew Delhi: There have been media reports claiming that Bharat Biotech, manufacturer of the indigenous COVID-19 vaccine – Covaxin, "had to skip certain...
DCGI panel to hold discussion on intranasal "Five Arms" booster dose iNCOVACC on Nov 15: Sources Ruchika Sharma14 Nov 2022 1:30 PM ISTIt has now announced that iNCOVACC (BBV154) has received approval under Restricted Use in Emergency Situation for ages 18 and above.
Bharat Biotech Covaxin 50 million doses set to expire early 2023 due to poor demand Ruchika Sharma7 Nov 2022 1:00 PM ISTHyderabad: Nearly 50 million doses of Bharat Biotech's COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no...
Vaccine maker Bharat Biotech evinces interest to invest in Karnataka Ruchika Sharma15 Oct 2022 11:20 AM IST"There is an intention to invest in Karnataka, where the industrial environment is favourable for business," said Dr. Ella.
Bharat Biotech Chief says PLI schemes should also focus on entities supporting production of branded pharma products Ruchika Sharma26 Sept 2022 11:15 AM IST"Lots of consumer durables, raw materials and packing materials were in short supply because we are not making them here in the country. It is very...
Denial of information on WHO suspension on Bharat Biotech Covaxin procurement: CIC issues show cause notice to CDSCO Ruchika Sharma16 Sept 2022 6:30 PM ISTIn response, CDSCO CPIO Sarkar gave a one line response, "No such information is available."
Intranasal COVID vaccine: Bharat Biotech seeks DCGI nod for phase 3 study of iNCOVACC in 5-18 age group Ruchika Sharma12 Sept 2022 11:28 AM ISTiNCOVACC is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein.
